Literature DB >> 15881184

[Extraintestinal complications in patients with ulcerative colitis].

Nobuhide Oshitani1, Kenji Watanabe, Shiro Nakamura, Kazuhide Higuchi, Tetsuo Arakawa.   

Abstract

Extraintestinal complications of patients with ulcerative colitis contribute to quality of life and mortality of the patients. Extraintestinal complications involve many organ systems. Skin, mucocutaneous, hepatobiliary, and joints complications are major extraintestinal complications. Some disorders correspond the activity of the colitis, other complications develop independently of the bowel inflammation. The purpose of this review is to update the clinicians concerning the etiology, clinical course and the therapy of the extraintestinal manifestations associated with ulcerative colitis.

Entities:  

Mesh:

Year:  2005        PMID: 15881184

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  6 in total

Review 1.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

2.  Original Research: Extract of Bambusae Caulis in Taeniam inhibits cigarette smoke-induced pulmonary and intestinal inflammation.

Authors:  Dahae Lim; Youngwoo Cho; Woogyeong Kim; Sehee Jeong; Young Pyo Jang; Jinju Kim
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-02

Review 3.  Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.

Authors:  Hui Wang; Jing-Shi Liu; Shao-Hua Peng; Xi-Yun Deng; De-Mao Zhu; Sara Javidiparsijani; Gui-Rong Wang; Dai-Qiang Li; Long-Xuan Li; Yi-Chun Wang; Jun-Ming Luo
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

4.  Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients.

Authors:  Yuksel Dogan; Aliye Soylu; Gulay A Eren; Sule Poturoglu; Can Dolapcioglu; Kenan Sonmez; Habibe Duman; Isa Sevindir
Journal:  Int J Med Sci       Date:  2011-09-16       Impact factor: 3.738

5.  Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease.

Authors:  Shaina Sekhri; Bharat Rao; Akanksha Mohananey; Poonam Beniwal-Patel; Alexandra Bruss; Daniel J Stein; Andres J Yarur
Journal:  BMJ Open Gastroenterol       Date:  2021-11

6.  Coexistence of Takayasu's Arteritis in Patients with Inflammatory Bowel Diseases.

Authors:  Camilla de Almeida Martins; Ana Elisa Rabe Caon; Carolina Bortolozzo Graciolli Facanali; Carlos Walter Sobrado; Sergio Carlos Nahas; Rosa Maria Rodrigues Pereira; Reuma Margalit-Yehuda; Uri Kopylov; Natalia Sousa Freitas Queiroz
Journal:  Gastroenterol Res Pract       Date:  2021-02-12       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.